Assessment of reinforcing effects of benztropine analogs and their effects on cocaine self-administration in rats: Comparisons with monoamine uptake inhibitors

Journal of Pharmacology and Experimental Therapeutics

Volumn 329, Issue 2, 2009, Pages 677-686

  Hiranita, Takato ^a   Soto, Paul L ^a   Newman, Amy H ^a   Katz, Jonathan L ^a  

^a NATIONAL INSTITUTE ON DRUG ABUSE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

(3 ALPHA[BIS(4' FLUOROPHENYL)METHOXY]TROPANE); (N ALLYL 3 ALPHA[BIS(4' FLUOROPHENYL)METHOXY]TROPANE); [N (N BUTYL) 3 ALPHA[BIS(4' FLUOROPHENYL)METHOXY]TROPANE]; AHN 1 055; AHN 2 005; BENZATROPINE; CITALOPRAM; COCAINE; JHW 007; METHYLPHENIDATE; MONOAMINE DERIVATIVE; NISOXETINE; UNCLASSIFIED DRUG; DOPAMINE UPTAKE INHIBITOR; DRUG DERIVATIVE;

ARTICLE; COMPARATIVE STUDY; CONTROLLED STUDY; DOSE RESPONSE; DRUG ABUSE; DRUG EFFECT; FOOD; INJECTION; MALE; NONHUMAN; PRIORITY JOURNAL; RAT; REINFORCEMENT; ANIMAL; ANIMAL BEHAVIOR; CHEMISTRY; COCAINE DEPENDENCE; DRUG SELF ADMINISTRATION; PSYCHOLOGICAL ASPECT; SPRAGUE DAWLEY RAT;

ANIMALS; BEHAVIOR, ANIMAL; BENZTROPINE; COCAINE; COCAINE-RELATED DISORDERS; DOPAMINE UPTAKE INHIBITORS; DOSE-RESPONSE RELATIONSHIP, DRUG; MALE; RATS; RATS, SPRAGUE-DAWLEY; REINFORCEMENT (PSYCHOLOGY); SELF ADMINISTRATION;

EID: 65649118524     PISSN: 00223565     EISSN: 15210103     Source Type: Journal    
DOI: 10.1124/jpet.108.145813     Document Type: Article

References (43)

1. Agoston GE, Wu JH, Izenwasser S, George C, Katz J, Kline RH, and Newman AH (1997) Novel N-substituted 3 alpha-[bis(4′-fluorophenyl)methoxy] tropane analogues: selective ligands for the dopamine transporter. J Med Chem 40:4329-4339.
2. Barrett AC, Miller JR, Dohrmann JM, and Caine SB (2004) Effects of dopamine indirect agonists and selective Dl-like and D2-like agonists and antagonists on cocaine self-administration and food maintained responding in rats. Neuropharmacology 47 (Suppl 1):256-273.
3. Bergman J, Madras BK, Johnson SE, and Spealman RD (1989) Effects of cocaine and related drugs in nonhuman primates: III. Self-administration by squirrel monkeys. J Pharmacol Exp Ther 251:150-155.
4. Beuming T, Kniazeff J, Bergmann ML, Shi L, Gracia L, Raniszewska K, Newman AH, Javitch JA, Weinstein H, Gether U, et al. (2008) Mapping of the binding sites for cocaine and dopamine in the dopamine transporter. Nat Neurosci 11:780-789.
5. Carroll FI, Fox BS, Kuhar MJ, Howard JL, Pollard GT, and Schenk S (2006) Effects of dopamine transporter selective 3-phenyltropane analogs on locomotor activity, drug discrimination, and cocaine self-administration after oral administration. Eur J Pharmacol 553:149-156.
6. Carroll FI, Runyon SP, Abraham P, Navarro H, Kuhar MJ, Pollard GT, and Howard JL (2004) Monoamine transporter binding, locomotor activity, and drug discrimination properties of 3-(4-substituted-phenyl)tropane-2-carboxylic acid methyl ester isomers. J Med Chem 47:6401-6409.
7. Desai RI, Kopajtic TA, French D, Newman AH, and Katz JL (2005a) Relationship between in vivo occupancy at the dopamine transporter and behavioral effects of cocaine, GBR 12909 [1-{2-[bis-(4-fluorophenyl)methoxy] ethyl}-4-(3-phenylpropy-l)piperazine], and benztropine analogs. J Pharmacol Exp Ther 315:397-404.
8. Desai RI, Kopajtic TA, Koffarnus M, Newman AH, and Katz JL (2005b) Identification of a dopamine transporter ligand that blocks the stimulant effects of cocaine. J Neurosci 25:1889-1893.
9. Dworkin SI, Lambert P, Sizemore GM, Carroll FI, and Kuhar MJ (1998) RTI-113 administration reduces cocaine self-administration at high occupancy of dopamine transporter. Synapse 30:49-55.
10. Gatley SJ, Pan D, Chen R, Chaturvedi G, and Ding YS (1996) Nfinities of methyl-phenidate derivatives for dopamine, norepinephrine and serotonin transporters. Life Sci 58:231-239.
11. Glowa JR, Wojnicki FH, Matecka D, Bacher JD, Mansbach RS, Balster RL, and Rice . KC (1995) Effects of dopamine reuptake inhibitors on food- and cocaine- ' maintained responding: I. Dependence on unit dose of cocaine. Exp Clin Psychopharmacol 3:219-231.
12. Grabowski J, Shearer J, Merrill J, and Negus SS (2004) Agonist-like, replacement pharmacotherapy for stimulant abuse and dependence. Addict Behav 29:1439-1464.
13. Howell LL and Byrd LD (1995) Serotonergic modulation of the behavioral effects of cocaine in the squirrel monkey. J Pharmacol Exp Ther 275:1551-1559.
14. Howell LL, Carroll FI, Votaw JR, Goodman MM, and Kimmel HL (2007) Effects of combined dopamine and serotonin transporter inhibitors on cocaine self-administration in rhesus monkeys. J Pharmacol Exp Ther 320:757-765.
15. Howell LL, Czoty PW, Kuhar MJ, and Carrol FI (2000) Comparative behavioral pharmacology of cocaine and the selective dopamine uptake inhibitor RTI-113 in the squirrel monkey. J Pharmacol Exp Ther 292:521-529.
16. Institute of Laboratory Animal Resources (1996) Guide for the Care and Use of Laboratory Animals, 7th ed, Institute of Laboratory Animal Resources, Commission on Life Sciences, National Research Council, Washington, DC.
17. Katz JL, Izenwasser S, Kline RH, Allen AC, and Newman AH (1999) Novel 3α-diphenylmethoxytropane analogs: selective dopamine uptake inhibitors with behavioral effects distinct from those of cocaine. J Pharmacol Exp Ther 288:302-315.
18. Katz JL, Kopajtic TA, Agoston GE, and Newman AH (2004) Effects of N-substituted analogs of benztropine: diminished cocaine-like effects in dopamine transporter ligands. J Pharmacol Exp Ther 309:650-660.
19. Kimmel HL, Negus SS, Wilcox KM, Ewing SB, Stehouwer J, Goodman MM, Votaw JR, Mello NK, Carroll FI, and Howell LL (2008) Relationship between rate of drug uptake in brain and behavioral pharmacology of monoamine transporter inhibitors in rhesus monkeys. Pharmacol Biochem Behav 90:453-462.
20. Kimmel HL, O'Connor JA, Carroll FI, and Howell LL (2007) Faster onset and dopamine transporter selectivity predict stimulant and reinforcing effects of cocaine analogs in squirrel monkeys. Pharmacol Biochem Behav 86:45-54.
21. 3H] JHW 007, a dopamine transporter ligand that blocks the effects of cocaine, in 67th Annual Scientific Meeting; 2006 Jun 17-22; Scotts-dale, AZ. The College on Problems of Drug Dependence, Philadelphia, PA.
22. Li SM, Newman AH, and Katz JL (2005) Place conditioning and locomotor effects of N-substituted, 4′,4′′-difluorobenztropine analogs in rats. J Pharmacol Exp Ther 313:1223-1230.
23. Lile JA, Morgan D, Freedland CS, Sinnott RS, Davies HM, and Nader MA (2000) Self-administration of two long-acting monoamine transport blockers in rhesus monkeys. Psychopharmacology (Berl) 152:414-421.
24. Lindsey KP, Wilcox KM, Votaw JR, Goodman MM, Plisson C, Carroll FI, Rice KC, and Howell LL (2004) Effects of dopamine transporter inhibitors on cocaine self-administration in rhesus monkeys: relationship to transporter occupancy determined by positron emission tomography neuroimaging. J Pharmacol Exp Ther 309:959-969.
25. Loland CJ, Desai RI, Zou MF, Cao J, Grundt P, Gerstbrein K, Sitte HH, Newman AH, Katz JL, and Gether U (2008) Relationship between conformational changes in the dopamine transporter and cocaine-like subjective effects of uptake inhibitors. Mol Pharmacol 73:813-823.
26. Mello NK and Negus SS (1996) Preclinical evaluation of pharmacotherapies for treatment of cocaine and opioid abuse using drug self-administration procedures. Neuropsychopharmacology 14:375- 424.
27. Newman AH, Kline RH, Allen AC, Izenwasser S, George C, and Katz JL (1995) Novel 4′-substituted and 4′,4′′-disubstituted 3 alpha-(diphenylmethoxy)tropane analogs as potent and selective dopamine uptake inhibitors. J Med Chem 38:3933-3940.
28. Othman AA, Syed SA, Newman AH, and Eddington ND (2007) Transport, metabolism, and in vivo population pharmacokinetics of the chloro benztropine analogs, a class of compounds extensively evaluated in animal models of drug abuse. J Pharmacol Exp Ther 320:344-353.
29. Raje S, Cao J, Newman AH, Gao H, and Eddington ND (2003) Evaluation of the blood-brain barrier transport, population pharmacokinetics, and brain distribution of benztropine analogs and cocaine using in vitro and in vivo techniques. J Pharmacol Exp Ther 307:801-808.
30. Ritz MC, Lamb RJ, Goldberg SR, and Kuhar MJ (1987) Cocaine receptors on dopamine transporters are related to self-administration of cocaine.Science 237: 1219-1223.
31. Rothman RB, Grieg N, Kim A, De Costa BR, Rice KC, Carroll FI, and Pert A (1992) Cocaine and GBR12909 produce equivalent motoric responses at different occupancy of the dopamine transporter. Pharmacol Biochem Behav 43:1135-1142.
32. Schenk S (2002) Effects of GBR 12909, WIN 35,428 and indatraline on cocaine self-administration and cocaine seeking in rats. Psychopharmacology (Berl) 160: 263-270.
33. Skjoldager P, Winger G, and Woods JH (1993) Effects of GBR 12909 and cocaine on cocaine-maintained behavior in rhesus monkeys. Drug Alcohol Depend 33:31-39.
34. Spealman RD, Madras BK, and Bergman J (1989) Effects of cocaine and related drugs in nonhuman primates: II. Stimulant effects on schedule-controlled behavior. J Pharmacol Exp Ther 251:142-149.
35. Tanda G, Ebbs A, Newman AH, and Katz JL (2005) Effects of 4′-chloro-3 alpha-(diphenylmethoxy)-tropane on mesostriatal, mesocortical, and mesolimbic dopamine transmission: comparison with effects of cocaine. J Pharmacol Exp Ther 313:613-620.
36. Taylor D and Ho BT (1978) Comparison of inhibition of monoamine uptake by cocaine, methylphenidate and amphetamine. Res Commun Chem Pathol Pharmacol 21:67-75.
37. Vaugeois JM, Bonnet JJ, Duterte-Boucher D, and Costentin J (1993) In vivo occupancy of the striatal dopamine uptake complex by various inhibitors does not predict their effects on locomotion. Eur J Pharmacol 230:195-201.
38. Vocci F and Ling W (2005) Medications development: Success and challenges. Pharmacol Ther 108:94-108.
39. Wee S, Carroll FI, and Woolverton WL (2006) A reduced rate of in vivo dopamine transporter binding is associated with lower relative reinforcing efficacy of stimulants. Neuropsychopharmacology 31:351-362.
40. Woolverton WL (1987) Evaluation of the role of norepinephrine in the reinforcing effects of psychomotor stimulants in rhesus monkeys. Pharmacol Biochem Behav 26:835-839.
41. Woolverton WL, Hecht GS, Agoston GE, Katz JL, and Newman AH (2001) Further studies of the reinforcing effects of benztropine analogs in rhesus monkeys. Psychopharmacology (Berl) 154:375-382.
42. Woolverton WL, Ranaldi R, Wang Z, Ordway GA, Paul IA, Petukhov P, and Kozikowski A (2002) Reinforcing strength of a novel dopamine transporter ligand: pharmacodynamic and pharmacokinetic mechanisms. J Pharmacol Exp Ther 303: 211-217.
43. Woolverton WL, Rowlett JK, Wilcox KM, Paul IA, Kline RH, Newman AH, and Katz JL (2000) 3′- and 4′-chloro-substituted analogs of benztropine: intravenous self-administration and in vitro radioligand binding studies in rhesus monkeys. Psy-chopharmacology (Berl) 147:426-435.